These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 945583)

  • 21. Chronic lithium treatment and dopamine-mediated behavior.
    Ebstein RP; Eliashar S; Belmaker RH; Ben-Uriah Y; Yehuda S
    Biol Psychiatry; 1980 Jun; 15(3):459-67. PubMed ID: 7189675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of cortical ablation on d-amphetamine-induced changes in striatal dopamine turnover and ascorbic acid catabolism in the rat.
    Desole MS; Miele M; Enrico P; Fresu L; Esposito G; De Natale G; Miele E
    Neurosci Lett; 1992 May; 139(1):29-33. PubMed ID: 1407680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Behavioral effects of amphetamine and apomorphine after striatal lesions in the rat.
    Antoniou K; Kafetzopoulos E
    Pharmacol Biochem Behav; 1992 Nov; 43(3):705-22. PubMed ID: 1448467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does cyclo(His-Pro) act like amphetamine?
    Mizuma H; Shimizu I; Hilton C; Prasad C
    Life Sci; 1994; 54(21):1625-33. PubMed ID: 8196482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue concentrations of p-hydroxynorephedrine in rats injected with d-amphetamine: effect of pretreatment with desipramine.
    Groppetti A; Costa E
    Life Sci; 1969 Jun; 8(11):653-65. PubMed ID: 5799285
    [No Abstract]   [Full Text] [Related]  

  • 26. [Antipsychotic drug modification of motor hyperactivity and stereotyped behavior induced by amphetamine in rats with lesions in the nigrostriatal and mesolymbic dopaminergic systems].
    Sánchez-Blázquez P; Fernández-Tomé MP; Fuentes JA; del Río J
    Arch Farmacol Toxicol; 1978 Apr; 4(1):66-8. PubMed ID: 29574
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of chronic amphetamine exposure on stereotyped behavior: implications for pathogenesis of l-dopa-induced dyskinesias.
    Klawans HL; Crossett P; Dana N
    Adv Neurol; 1975; 9():105-12. PubMed ID: 1170714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioural evidence for supersensitivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine.
    Spyraki C; Fibiger HC
    Eur J Pharmacol; 1981 Sep; 74(2-3):195-206. PubMed ID: 7198991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interactions of various drugs with amphetamine.
    Garattini S; Jori A; Samanin R
    Ann N Y Acad Sci; 1976; 281():409-25. PubMed ID: 798529
    [No Abstract]   [Full Text] [Related]  

  • 30. Time course of the development of the enhanced behavioral and biochemical responses to amphetamine after pretreatment with amphetamine.
    Kolta MG; Shreve P; De Souza V; Uretsky NJ
    Neuropharmacology; 1985 Sep; 24(9):823-9. PubMed ID: 4058677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antagonistic effects of stimulation of the paramedian reticular nucleus in the rat medulla oblongata and of amphetamine on locomotor activity and striatal release of dopamine-like material.
    Lin MT; Chuang SF; Li YC; Young MS; Chai CY
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Sep; 348(3):258-63. PubMed ID: 8232603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Some observations on the behavioural responses to metoclopramide in the pig and the guinea pig [proceedings].
    Ely N; Rumble IR; Sharman DF
    Br J Pharmacol; 1978 Mar; 62(3):392P-393P. PubMed ID: 565234
    [No Abstract]   [Full Text] [Related]  

  • 33. Evidence against the involvement of false neurotransmitters in tolerance to amphetamine-induced hyperthermia in the rat.
    Sever PS; Caldwell J; Williams RT
    J Pharm Pharmacol; 1974 Oct; 26(10):823-6. PubMed ID: 4156544
    [No Abstract]   [Full Text] [Related]  

  • 34. The potentiation of the non-behavioural effects of amphetamine by carbon disulphide.
    Caroldi S; Magos L; Jarvis J; Forshaw P; Snowden RT
    J Appl Toxicol; 1987 Feb; 7(1):63-6. PubMed ID: 3611599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spontaneous and amphetamine-induced behavior after bilateral injection of ethanolamine-O-sulfate into the substantia nigra.
    Koob GF; Del Fiacco M; Iversen SD
    Brain Res; 1978 May; 146(2):313-23. PubMed ID: 565665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of naloxone and diprenorphine on amphetamine-stimulated behavior in guinea pigs and rats.
    Andrews JS; Holtzman SG
    Neuropharmacology; 1987 Aug; 26(8):1115-20. PubMed ID: 3658118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple daily amphetamine administration: behavioral and neurochemical alterations.
    Segal DS; Weinberger SB; Cahill J; McCunney SJ
    Science; 1980 Feb; 207(4433):905-7. PubMed ID: 7188815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behavioral depression and its neurochemical correlates at high doses of d-amphetamine in rats.
    Copeland RL; Aulakh CS; Bhattacharyya AK; Pradhan SN
    Neuropharmacology; 1980 Oct; 19(10):1027-30. PubMed ID: 7191484
    [No Abstract]   [Full Text] [Related]  

  • 39. An observational method for quantifying the behavioural effects of dopamine agonists: contrasting effects of d-amphetamine and apomorphine.
    Fray PJ; Sahakian BJ; Robbins TW; Koob GF; Iversen SD
    Psychopharmacology (Berl); 1980; 69(3):253-9. PubMed ID: 6774363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Birth insult alters dopamine-mediated behavior in a precocial species, the guinea pig. Implications for schizophrenia.
    Vaillancourt C; Boksa P
    Neuropsychopharmacology; 2000 Dec; 23(6):654-66. PubMed ID: 11063921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.